Positron Emission Tomography Market Analysis

Positron Emission Tomography Market Analysis

Positron emission tomography market share from the full ring PET scanner segment is predicted to record nearly 5.8% CAGR from 2023 to 2032. Therapeutic applications including oncology, cardiology, neurology, and psychiatry are largely utilizing full ring PET scanners. The adoption and advanced full ring PET scanners are likely to be driven by rising incidence of cancer, the growing geriatric population, demand for personalized medicine, developments in PET technology, and growing awareness of PET imaging over the forecast period.
 

Positron emission tomography market share from the Lutetium Oxyorthosilicate (LSO) segment is predicted to surpass USD 1.1 billion by 2032. LSO PET scanners have grown in popularity over time due to enhanced spatial resolution, high sensitivity, and the capacity to acquire images more quickly than previous-generation PET scanners. Healthcare practitioners use Monoverses PET scanners to diagnose and treat a variety of illnesses owing to their significant advantages over earlier generations of PET scanners.
 

Positron emission tomography market share from the diagnostic centers segment is predicted to observe more than 6% CAGR between 2023 and 2032. These healthcare facilities are extending their services to provide patients with a wider variety of diagnostic alternatives. The inclusion of PET imaging in these centers enhances their ability to offer more thorough testing for multiple disorders. PET scanners were previously expensive and were primarily utilized only in hospitals. With advancements in technology, the cost of purchasing PET scanners may reduce in the ensuing years, supporting its deployment in diagnostic centers.
 

North America positron emission tomography market is expected to reach over USD 1.2 billion by 2032 due to the adoption of new medical technologies and the presence of developed countries in the region. The US has some of the best healthcare facilities that perform PET scans. The increasing disposable income of the population and rising healthcare spending are some of the factors that will promote market expansion in North America.